Knitting and untying the protein network: Modulation of protein ensembles as a therapeutic strategy

被引:20
作者
Gordo, Susana [1 ]
Giralt, Ernest [1 ,2 ]
机构
[1] Inst Res Biomed, Barcelona 08028, Spain
[2] Univ Barcelona, Dept Organ Chem, E-08028 Barcelona, Spain
关键词
the protein network; protein-protein interactions; protein interfaces; surface recognition; drug discovery; protein p53; INTRINSICALLY UNSTRUCTURED PROTEINS; P53; PATHWAY; MUTANT P53; SURFACE RECOGNITION; MISFOLDING DISEASES; SMALL MOLECULES; DRUG DISCOVERY; BINDING-SITES; PHARMACOLOGICAL CHAPERONES; P53-MDM2; INTERACTION;
D O I
10.1002/pro.43
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteins constitute the working machinery and structural support of all organisms. In performing a given function, they must adopt highly specific structures that can change with their level of activity, often through the direct or indirect action of other proteins. Indeed, proteins typically function within an ensemble, rather than individually. Hence, they must be sufficiently flexible to interact with each other and execute diverse tasks. The discovery that errors within these groups can ultimately cause disease has led to a paradigm shift in drug discovery, from an emphasis on single protein targets to a holistic approach whereby entire ensembles are targeted.
引用
收藏
页码:481 / 493
页数:13
相关论文
共 123 条
[1]   Electrostatic rate enhancement and transient complex of protein-protein association [J].
Alsallaq, Ramzi ;
Zhou, Huan-Xiang .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 71 (01) :320-335
[2]   Therapy through chaperones: Sense or antisense? - Cystic fibrosis as a model disease [J].
Amaral, MD .
JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 (2-3) :477-487
[3]   Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs [J].
Arakawa, Tsutomu ;
Ejima, Daisuke ;
Kita, Yoshiko ;
Tsumoto, Kouhei .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2006, 1764 (11) :1677-1687
[4]   Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain [J].
Ariumi, Y ;
Kaida, A ;
Hatanaka, M ;
Shimotohno, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (02) :556-561
[5]   Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream [J].
Arkin, MR ;
Wells, JA .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :301-317
[6]   A dissection of specific and non-specific protein - Protein interfaces [J].
Bahadur, RP ;
Chakrabarti, P ;
Rodier, F ;
Janin, J .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 336 (04) :943-955
[7]   p53 contains large unstructured regions in its native state [J].
Bell, S ;
Klein, C ;
Müller, L ;
Hansen, S ;
Buchner, J .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 322 (05) :917-927
[8]  
BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.bb.14.060185.001023
[9]   Strategies to search and design stabilizers of protein-protein interactions: A feasibility study [J].
Block, Peter ;
Weskamp, Nils ;
Wolf, Alexander ;
Klebe, Gerhard .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 68 (01) :170-186
[10]   Some p53-binding proteins that can function as arbiters of life and death [J].
Braithwaite, A. W. ;
Del Sal, G. ;
Lu, X. .
CELL DEATH AND DIFFERENTIATION, 2006, 13 (06) :984-993